FDA approves Merck vaccine against pneumococcal disease designed for adults
Zoom in iconArrows pointing outwards Merck's new pneumococcal vaccine. Courtesy: Merck The Food and Drug Administration on Monday approved merckThe…
Vaxcyte Inc.
Biotech stocks are ready to break out. They just need one more thing
As debate continues over when the Federal Reserve might begin cutting interest rates, biotech industry analysts argue that the case…